| abstract |
A docetaxol albumin nanoparticle pharmaceutical composition, a preparation method therefor, and a use thereof manufacturing drugs for treating cancer. The pharmaceutical composition comprises docetaxol, albumin and amino acids, wherein the weight ratio between albumin and docetaxol is no more than 50, preferably 20:1 - 1:1, and the weight ratio between amino acids and docetaxol is not less than 0.5, preferably 1:1 - 20:1. |